Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.3 USD | +0.85% |
|
+4.54% | -23.05% |
Jul. 04 | Genscript Biotech's Phase 3 Multiple Myeloma Drug Trial Yields Positive Results | MT |
Jul. 02 | Legend Biotech Says Myeloma Drug Shows Positive Overall Survival Results | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.05% | 8.44B | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Transcript : Legend Biotech Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 02